Accepted for Publication: February 24, 2022.
Published: April 20, 2022. doi:10.1001/jamanetworkopen.2022.7650
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Ridgway JP et al. JAMA Network Open.
Corresponding Author: Jessica P. Ridgway, MD, Department of Medicine, University of Chicago, 5841 S Maryland Ave, MC 5065, Chicago, IL 60637 (Jessica.ridgway@uchospitals.edu).
Author Contributions: Dr Robicsek had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Tideman, Wright, Robicsek.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Ridgway, Wright, Robicsek.
Critical revision of the manuscript for important intellectual content: Tideman, Wright, Robicsek.
Statistical analysis: Tideman, Robicsek.
Obtained funding: Robicsek.
Administrative, technical, or material support: Ridgway, Wright, Robicsek.
Supervision: Wright, Robicsek.
Conflict of Interest Disclosures: None reported.
1.Chen
X , Chen
Z , Azman
AS ,
et al. Neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants induced by natural infection or vaccination: a systematic review and pooled analysis.
Clin Infect Dis. 2022;74(4):734-742. doi:
10.1093/cid/ciab646PubMedGoogle ScholarCrossref 3.Hansen
CH , Michlmayr
D , Gubbels
SM , Mølbak
K , Ethelberg
S . Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study.
Lancet. 2021;397(10280):1204-1212. doi:
10.1016/S0140-6736(21)00575-4
PubMedGoogle ScholarCrossref 4.Sheehan
MM , Reddy
AJ , Rothberg
MB . Reinfection rates among patients who previously tested positive for coronavirus disease 2019: a retrospective cohort study.
Clin Infect Dis. 2021;73(10):1882-1886. doi:
10.1093/cid/ciab234PubMedGoogle ScholarCrossref